Literature DB >> 82142

Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation.

J L Anderson, R E Fowles, C P Bieber, E B Stinson.   

Abstract

A review of lymphomas developing in recipients of cardiac allografts has yielded significant risk factors. Frequency varied strikingly according to original cardiac disease: lymphoma developed in 6 of 37 patients with prior idiopathic cardiomyopathy (I.C.M.) but in one of 54 patients with prior coronary-artery disease (C.A.D.). All patients who developed lymphomas were aged under 40. Combination of both risk factors (I.C.M. and age less than 40) produces a sub-group with a highly significantly increased risk of lymphoma. I.C.M., but not C.A.D., is characterised by a defect in mitogen-induced mononuclear-cell suppressor activity. It is postulated that defective regulation in the immune systems of younger patients under chronic alloantigen stimulation may allow lymphoid proliferation to proceed to lymphoreticular malignancy. Immunosuppressive agents such as azathioprine may exert a co-oncogenic effect.

Entities:  

Mesh:

Year:  1978        PMID: 82142     DOI: 10.1016/s0140-6736(78)92156-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Cancer after cardiac transplantation.

Authors: 
Journal:  Br Med J       Date:  1979-02-24

2.  Cyclosporin A and the media.

Authors:  R Y Calne; P McMaster; D B Evans
Journal:  Br Med J       Date:  1980-01-05

Review 3.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

4.  A case of congestive cardiomyopathy. Demonstration at the Royal College of Physicians of London.

Authors: 
Journal:  Br Med J       Date:  1980-03-01

5.  Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis.

Authors:  B Maisch
Journal:  Heart Vessels Suppl       Date:  1985

6.  Immunity in dilated cardiomyopathy.

Authors:  S K Das; J T Cassidy; S A Huber
Journal:  Heart Vessels Suppl       Date:  1985

7.  The use of cyclosporin A in clinical organ grafting.

Authors:  R Y Calne; D J White
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

8.  Cellular immunity in congestive cardiomyopathy. Hypersensitivity to cardiac antigens.

Authors:  P J Lowry; R A Thompson; W A Littler
Journal:  Br Heart J       Date:  1985-04

9.  Evaluation of suppressor immune regulatory function in idiopathic congestive cardiomyopathy and rheumatic heart disease.

Authors:  J L Anderson; J H Greenwood; H Kawanishi
Journal:  Br Heart J       Date:  1981-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.